Yahoo Canada Web Search

Search results

1. www.dea.gov › files › 2018-06Drugs of Abuse (2017 Edition) - DEA.gov

   www.dea.gov › files › 2018-06

   • The drug or other substance has a high potential for abuse. • The drug or other substance has no currently accepted medical use in treatment in the United States. • There is a lack of accepted safety for use of the drug or other substance under medical supervision. • Examples of Schedule I substances include heroin, gamma

   • File Size: 3MB

   • Page Count: 94

2. www.betweensessions.com › wp-content › uploadsBreaking Free of Addiction - Between Sessions

   www.betweensessions.com › wp-content › uploads

   BREAKING FREE OF ADDICTION Introduc0on Breaking free of drug and alcohol addic0on is one of the bravest things you’ll ever do. While some experts might claim to know “the answer,” there is no right answer. In other words, one size does not fit all. Some people who follow a rigid model end up relapsing. Some who try on their own do just ...

   • File Size: 4MB

   • Page Count: 182

3. unodc.org › nonmedical-use-prescription-drugsThe non-medical use of prescription drugs

   unodc.org › nonmedical-use-prescription-drugs

   • DISCUSSION PAPER
   • Acknowledgements
   • Ariadna M. Viglione
   • Antonio Calabrese
   • Malcolm Dobbin
   • Jose Manoel Bertoloti
   • Wang Qianrong
   • Wang Xiangdong
   • Li Weihua
   • Shan Xiaojing
   • Emilia Ramírez Alfaro
   • Timea Kahlesz
   • Hedvig Zajzon-Boruzs
   • Rajat Ray
   • Salim Baddoura
   • Audronė Astrauskienė
   • Fayzal Sulliman
   • Elvis Shiweda
   • Elmer Punzalan
   • Lubomir Okruhlica
   • David Bayever
   • Mohamed Al Kharkhi
   • Volodymyr Beznogykh
   • Adam Bisaga
   • Wilson Compton
   • Sidney Schnoll
   • Ziggie Malyniwsky
   • Gisela Wieser-Herbeck
   • Hanifa Rebbani
   • Giovanna Campello
   • Katri Tala
   • Elizabeth Saenz
   • Anja Busse
   • Beate Hammond
   • Nicolas Clark
   • Chris van der Burgh
   • 1. Introduction
   • International Narcotics Control Board
   • 6. The role of the medical and pharmaceutical sectors
   • Supervised daily dosing
   • Preventing diversion whilst ensuring that prescription drugs are available to those who need them
   • Recognition and diagnosis
   • Addressing co-morbidity
   • Pharmacological treatments
   • Non-medical use of prescription drugs and the treatment of pain
   • 9. Conclusions and recommendations
   • Benzodiazepine
   • Controlled substances
   • DEA number
   • Dependence
   • INCB—International Narcotics Control Board
   • Non-medical use (of prescription drugs)
   • Over-the-counter drug
   • Self-medication
   • Stimulant
   • Tranquilizer
   • Dihydrocodeine,

   Photo credits Front cover photographs: left ©iStockphoto.com/Marcela Barsse, centre ©iStockphoto.com/oonal, right ©iStockphoto.com/aurumarcus UNITED NATIONS OFFICE ON DRUGS AND CRIME Vienna

   See full list on unodc.org

   Many individuals contributed to the preparation of the present publication, The non- medical use of prescription drugs: policy direction issues. UNODC extends its deep apprecia-tion to the following experts who participated in the technical consultation meeting and provided substantive comments to the draft document. Participants:

   See full list on unodc.org

   Secretaria de programación para la Prevención de la Drogadicción y la Lucha contra el Narcotráfico Argentina

   See full list on unodc.org

   Comisión Nacional Coordinadora de Políticas Públicas en materia de Prevención y Control del Tráfico Ilícito de Estupefacientes Argentina

   See full list on unodc.org

   Senior Medical Advisor on Alcohol and Drugs to the Mental Health and Drugs Division of the Victorian Department of Human Services Australia

   See full list on unodc.org

   Brazil’s National Secretariat on Drug Policies Brazil

   See full list on unodc.org

   Deputy Secretary-General, China National Narcotics Control Commission China

   See full list on unodc.org

   Director, Precursor Chemicals Control Division, Ofice of China National Narcotics Control Commission China

   See full list on unodc.org

   Oficer, Department of Drug Safety and Inspection, China State Food and Drug Administration China

   See full list on unodc.org

   Oficer, International Cooperation Division, Ofice of China National Narcotics Control Commission China

   See full list on unodc.org

   Instituto Costarricense sobre Drogas: Jefe Unidad de Control y Fiscalización de Precursores y coordinadora del Ámbito de Control y Fiscalización del Plan Nacional sobre Drogas Costa Rica

   See full list on unodc.org

   Deputy Head of Department of the Ministry of National Resources (former Ministry of Health), Department for Pharmaceuticals and Medical Devices Hungary

   See full list on unodc.org

   Head of the Narcotic Department of the Ofice for Health Authorization and Administrative Procedures Hungary

   See full list on unodc.org

   Head of the Department of Psychatry of AIIMS India

   See full list on unodc.org

   First Secretary, Alternate Permanent Representative to UNOV Lebanon

   See full list on unodc.org

   Director of the Drug Control Department under the Government of the Republic of Lithuania Lithuania

   See full list on unodc.org

   Public Health Specialist, Methadone Programme Manager, Ministry of Health Mauritius

   See full list on unodc.org

   First Secretary, Permanent Mission of Namibia to the United Nations Namibia

   See full list on unodc.org

   Assistant Secretary of the Department of Health of the Philippines Philippines

   See full list on unodc.org

   Director of the Centre for Drugs Abuse Treatment Slovak Republic

   See full list on unodc.org

   Head of Division, Pharmacotherapy and Pharmacy Practice, Department of Pharmacy and Pharmacology, Faculty of Health Sciences, University of Witwatersrand Medical School South Africa

   See full list on unodc.org

   Psychiatrist, National Rehabilitation Centre United Arab Emirates

   See full list on unodc.org

   Chief of section Ukrainian Medical and Monitoring Centre for Alcohol and Drugs Ministry of Health of Ukraine

   See full list on unodc.org

   Associate Professor of Clinical Psychiatry in the Department of Psychiatry at the College of Physicians and Surgeons of Columbia University Research Scientist at the New York State Psychiatric Institute United States

   See full list on unodc.org

   Director of the Division of Epidemiology, Services and Prevention Research at the National Institute on Drug Abuse (NIDA) United States

   See full list on unodc.org

   Vice President, Pharmaceutical Risk Management Services Pinney Associates. United States

   See full list on unodc.org

   Ethylmorphine, Nicocodine, Nicodicodine, Norcodeine and

   See full list on unodc.org

   Ethylmorphine, Nicocodine, Nicodicodine, Norcodeine and

   See full list on unodc.org

   Ethylmorphine, Nicocodine, Nicodicodine, Norcodeine and

   See full list on unodc.org

   Ethylmorphine, Nicocodine, Nicodicodine, Norcodeine and

   See full list on unodc.org

   Ethylmorphine, Nicocodine, Nicodicodine, Norcodeine and

   See full list on unodc.org

   Ethylmorphine, Nicocodine, Nicodicodine, Norcodeine and

   See full list on unodc.org

   Ethylmorphine, Nicocodine, Nicodicodine, Norcodeine and

   See full list on unodc.org

   Ethylmorphine, Nicocodine, Nicodicodine, Norcodeine and

   See full list on unodc.org

   Ethylmorphine, Nicocodine, Nicodicodine, Norcodeine and

   See full list on unodc.org

   Ethylmorphine, Nicocodine, Nicodicodine, Norcodeine and

   See full list on unodc.org

   Ethylmorphine, Nicocodine, Nicodicodine, Norcodeine and

   See full list on unodc.org

   Ethylmorphine, Nicocodine, Nicodicodine, Norcodeine and

   See full list on unodc.org

   Ethylmorphine, Nicocodine, Nicodicodine, Norcodeine and

   See full list on unodc.org

   Ethylmorphine, Nicocodine, Nicodicodine, Norcodeine and

   See full list on unodc.org

   Ethylmorphine, Nicocodine, Nicodicodine, Norcodeine and

   See full list on unodc.org

   Ethylmorphine, Nicocodine, Nicodicodine, Norcodeine and

   See full list on unodc.org

   Ethylmorphine, Nicocodine, Nicodicodine, Norcodeine and

   See full list on unodc.org

   Ethylmorphine, Nicocodine, Nicodicodine, Norcodeine and

   See full list on unodc.org

   Ethylmorphine, Nicocodine, Nicodicodine, Norcodeine and

   See full list on unodc.org

   Ethylmorphine, Nicocodine, Nicodicodine, Norcodeine and

   See full list on unodc.org

   Ethylmorphine, Nicocodine, Nicodicodine, Norcodeine and

   See full list on unodc.org

   Ethylmorphine, Nicocodine, Nicodicodine, Norcodeine and

   See full list on unodc.org

   Ethylmorphine, Nicocodine, Nicodicodine, Norcodeine and

   See full list on unodc.org

   Ethylmorphine, Nicocodine, Nicodicodine, Norcodeine and

   See full list on unodc.org

   Ethylmorphine, Nicocodine, Nicodicodine, Norcodeine and

   See full list on unodc.org

   Ethylmorphine, Nicocodine, Nicodicodine, Norcodeine and

   See full list on unodc.org

   Ethylmorphine, Nicocodine, Nicodicodine, Norcodeine and

   See full list on unodc.org

   Ethylmorphine, Nicocodine, Nicodicodine, Norcodeine and

   See full list on unodc.org

   Ethylmorphine, Nicocodine, Nicodicodine, Norcodeine and

   See full list on unodc.org

   Ethylmorphine, Nicocodine, Nicodicodine, Norcodeine and

   See full list on unodc.org

   Ethylmorphine, Nicocodine, Nicodicodine, Norcodeine and

   See full list on unodc.org

   • File Size: 1MB

   • Page Count: 96

4. www.ccsa.ca › sites › defaultWhat Is Pharmacology? - CCSA

   www.ccsa.ca › sites › default

   Drugs act on the brain’s reward system in a similar way, producing a release of dopamine that leads to feelings of pleasure. People often use drugs for these feelings of pleasure and repeat the behaviour that leads to these rewards. In this way, the reward system reinforces behaviours that support drug use.

   • File Size: 377KB

   • Page Count: 5

5. nida.nih.gov › files › commonly_abused_drugsCommonly Abused Drugs - National Institute on Drug Abuse (NIDA)

   nida.nih.gov › files › commonly_abused_drugs

   the chart below for drugs where there is enough scientific evidence to connect the drug use to specific negative effects. For information about treatment options for drug addiction, see NIDA’s Treatment pages. For drug use trends, see our Trends and Statistics page. The following drugs are included in this resource: Alcohol Ayahuasca

6. nida.nih.gov › sites › defaultUnderstanding Drug Abuse and Addiction

   nida.nih.gov › sites › default

   ever, and we also know that drug addiction can be successfully treated to help people stop abusing drugs and lead productive lives. Drug abuse and addiction have negative consequences for individuals and for society. Estimates of the total overall costs of substance abuse in the United States, including productivity and health- and

7. People also ask

   What is a non-sanctioned use of a controlled substance called?

   • The non-sanctioned use of controlled substances is called drug abuse. When these substances are used in a manner or amount inconsistent with the legitimate medical use, as outlined in Schedules I through V of the CSA, it is considered drug abuse.

   drugs of abuse (2017 edition) - dea.gov

   www.dea.gov/sites/default/files/2018-06/drug_of_abuse.pdf

   See all results for this question

   What is non-sanctioned drug use?

   • The non-sanctioned use of substances controlled in Schedules I through V of the CSA is considered drug abuse. While legal pharmaceuticals placed under control in the CSA are prescribed and used by patients for medical treatment, the use of these same pharmaceuticals outside the scope of sound medical practice is drug abuse.

   drugs of abuse (2017 edition) - dea.gov

   www.dea.gov/sites/default/files/2018-06/drug_of_abuse.pdf

   See all results for this question

   What if a drug does not have a potential for abuse?

   • If a drug does not have the potential for abuse, it cannot be controlled. Although the term ‘potential for abuse’ is not defined in the CSA, there is much discussion of the term in the legislative history of the Act. The following items are indicators that a drug or other substance has a potential for abuse:

   drugs of abuse (2017 edition) - dea.gov

   www.dea.gov/sites/default/files/2018-06/drug_of_abuse.pdf

   See all results for this question

   What are the risks of using a drug or other substance?

   • A drug or other substance with a high potential for abuse and no currently accepted medical use in treatment in the United States is considered to have risks. The lack of accepted safety for use of the drug or other substance under medical supervision further emphasizes these risks.

   drugs of abuse (2017 edition) - dea.gov

   www.dea.gov/sites/default/files/2018-06/drug_of_abuse.pdf

   See all results for this question

   What is non-medical use of prescription drugs?

   • The growing non-medical use of prescription drugs is a global health concern. Such usage can be defined as the taking of prescription drugs, whether obtained by prescription or otherwise, other than in the manner or for the reasons or time period prescribed, or by a person for whom the drug was not prescribed.

   The non-medical use of prescription drugs - United Nations Office on

   unodc.org/documents/drug-prevention-and-treatment/nonmedical-use-prescription-drugs.pdf

   See all results for this question

   How does non-medical use affect prescription drugs?

   • Increased non-medical use creates a greater demand for prescription medications, leading to new sources of diversion from medical to non-medical use or to the production of coun-terfeit drugs (United States, Ofice of National Drug Control Policy, 2008).

   The non-medical use of prescription drugs - United Nations Office on

   unodc.org/documents/drug-prevention-and-treatment/nonmedical-use-prescription-drugs.pdf

   See all results for this question

8. wdr.unodc.org › wdr2020 › field2020 - United Nations : Office on Drugs and Crime

   wdr.unodc.org › wdr2020 › field

   about the distinctions between “drug use”, “drug misuse” and “drug abuse”, the neutral term “drug use” is used in the World Drug Report. The term “misuse” is used only to denote the non-medical use of prescription drugs. All uses of the word “drug” and the term “drug use” in the World Drug Report refer to substances con-